- Home
- KNSA vs DOLE Comparison
KNSA vs DOLE Comparison
Compare KNSA & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- DOLE
- Stock Information
- Founded
- KNSA 2015
- DOLE 1851
- Country
- KNSA United Kingdom
- DOLE Ireland
- Employees
- KNSA N/A
- DOLE N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- DOLE Farming/Seeds/Milling
- Sector
- KNSA Health Care
- DOLE Consumer Staples
- Exchange
- KNSA Nasdaq
- DOLE Nasdaq
- Market Cap
- KNSA 1.4B
- DOLE 1.3B
- IPO Year
- KNSA 2018
- DOLE 2021
- Fundamental
- Price
- KNSA $20.02
- DOLE $13.63
- Analyst Decision
- KNSA Strong Buy
- DOLE Buy
- Analyst Count
- KNSA 5
- DOLE 3
- Target Price
- KNSA $36.60
- DOLE $16.67
- AVG Volume (30 Days)
- KNSA 567.6K
- DOLE 400.2K
- Earning Date
- KNSA 02-25-2025
- DOLE 02-26-2025
- Dividend Yield
- KNSA N/A
- DOLE 2.35%
- EPS Growth
- KNSA N/A
- DOLE 71.64
- EPS
- KNSA N/A
- DOLE 1.96
- Revenue
- KNSA $384,098,000.00
- DOLE $8,380,134,000.00
- Revenue This Year
- KNSA $60.10
- DOLE $2.93
- Revenue Next Year
- KNSA $34.22
- DOLE $0.61
- P/E Ratio
- KNSA N/A
- DOLE $8.74
- Revenue Growth
- KNSA 54.41
- DOLE 2.00
- 52 Week Low
- KNSA $16.56
- DOLE $11.03
- 52 Week High
- KNSA $28.15
- DOLE $17.12
- Technical
- Relative Strength Index (RSI)
- KNSA 53.15
- DOLE 50.61
- Support Level
- KNSA $19.31
- DOLE $13.37
- Resistance Level
- KNSA $20.20
- DOLE $13.96
- Average True Range (ATR)
- KNSA 0.80
- DOLE 0.29
- MACD
- KNSA 0.06
- DOLE 0.01
- Stochastic Oscillator
- KNSA 72.80
- DOLE 60.71
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW and Fresh Vegetables. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.